// App-Quantinova.ai

P001 : Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on the IL23/IFNg axis

Researchers

Presenter

  • Lo, J

Principal Investigators

  • Cozzetto, D

  • Madgwick, M

  • Sieh, J.Y.X.S

  • Olbei, M

  • Alexander, J.L

  • Miguens Blanco, J

  • Kudo, H

  • Ibraheim, H

  • Liu, Z

  • Castro Seoane, R

  • Goldin, R

  • Marchesi, J

  • Korcsmaros, T

  • Lord, G

  • Powell, N

Medical Centers

  • Imperial College London, Department of Metabolism Digestion and Reproduction, London, United Kingdom

  • Earlham Institute, Organisms and Ecosystems, Norwich, United Kingdom

  • Quadram Institute Bioscience, Gut Microbes and Health, Norwich, United Kingdom

  • School of Immunology & Microbial Sciences, King's College London, London, United Kingdom

  • University of Manchester, School of Translational Medicine, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • Anti-CTLA4

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved